DCF — MYRTUE MEDICAL CENTER
Enterprise Value: $-72.7M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-72.7M
Enterprise Value
$-23.2M
PV of Cash Flows
$-49.5M
PV of Terminal Value
$-79.8M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $50.3M | $-4.4M | -9.0% | $-6.6M | $-6.0M |
| Year 2 | $51.8M | $-4.1M | -8.0% | $-6.2M | $-5.2M |
| Year 3 | $53.4M | $-3.6M | -7.0% | $-5.9M | $-4.4M |
| Year 4 | $55.0M | $-3.5M | -6.0% | $-5.8M | $-4.0M |
| Year 5 | $56.6M | $-3.4M | -6.0% | $-5.8M | $-3.6M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-72.7M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$48.8M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.09327077621200412
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5